Dolby Laboratories Inc (NYSE: DLB) has reported earnings for its second fiscal quarter (ending March 31) of $1.02 versus $1.00 for the same period a year ago — an increase of 2%. However, this result fell short of the consensus estimate of $1.21 by $-0.19. For the latest four quarters through March 31, E.P.S. were $1.99 versus $2.52 for the same period a year ago — a decline of -21%.
Recent Price Action
On 5/2/24, Dolby Laboratories Inc (NYSE: DLB) stock enjoyed a large increase of 2.7%, closing at $79.71. Moreover, exceptionally high trading volume at 200% of normal accompanied the advance. The stock has performed in line with the market over the last nine months and is unchanged during the last week.
Current PriceTarget Research Rating
DLB is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to exceed the cost of capital.
Dolby Laboratories has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Dolby Laboratories has a slightly negative Power Rating of 40 and a poor Appreciation Score of 18, with the Lowest Value Trend Rating the result.
Rating Review
In light of this new information we are reviewing our current Overall Rating of F. This review will be completed in the next several days.
Be the first to comment